Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 29, Issue 1, 2006, Pages 21-26

  Berthelet, Eric ^a   Truong, Pauline T ^a   Lesperance, Mary ^b   Lim, Jan T W ^a   Wai, Elaine S ^a   MacNeil, Mary V ^a   Liu, Mitchell ^a   Joe, Howard ^a   Olivotto, Ivo A ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Radiotherapy; Relapse; Small cell lung cancer; Survival; Timing, diagnosis

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CONSULTATION; CONTROLLED STUDY; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; ONCOLOGY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; CANCER STAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; LUNG TUMOR; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RETROSPECTIVE STUDY; SKULL IRRADIATION; SMALL CELL CARCINOMA; SURVIVAL; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644870909     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000195092.25516.19     Document Type: Article

References (46)

1. Pignon J, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med. 1992;327:1618-1624.
2. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small cell carcinoma of the lung? A meta-analysis. J Clin Oncol. 1992;10:890-895.
3. Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1993;11:336-344.
4. Turrisi AT 3rd, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;34:265-271.
5. Elias AD. Small-cell lung cancer: state-of-the-art therapy in 1996. Chest. 1997;112(supp):251S-258S.
6. Ludbrook JJS, Truong PT, MacNeil MV, et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiation Oncol Biol Phys. 2003;55:1321-1330.
7. Tinnemans MM, Schutte B, Lenders MH, et al. Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling. Br J Cancer. 1993;67:1217-1222.
8. Vescio RA, Connors KM, Bordin GM, et al. The distinction of small cell and non-small cell lung cancer by growth in native-state histoculture. Cancer Res. 1990;50:6095-6099.
9. Perry MC, Eaton WL, Propert KJ, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med. 1987;316:912-918.
10. Perry MC, Herndon JE 3rd, Eaton WL, et al. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083. J Clin Oncol. 1998;16:2466-2467.
11. Work E, Nielsen OS, Bentzen SM, et al. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group. J Clin Oncol. 1997;15:3030-3037.
12. Lindsay EJ, Spiro S, O'Donnell KM, et al. A randomised study of timing of thoracic irradiation in small cell lung cancer (SCLC) - study 8. Lung Cancer. 2003;41:S23.
13. Jeremic B, Shibamoto Y, Acimovic L, et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol. 1997;15:893-900.
14. De Ruysscher D, Vansteenkiste J. Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects. Radiother Oncol. 2000;55:1-9.
15. Hutchins LF, Unger JM, Crowley JJ, et al. Under-representation of patients 65 years or older in cancer treatment trials. N Engl J Med. 1999;341:2061-2067.
16. Fourquet A, Dreyfus H, Colombani H, et al. Influence of surgery-radiotherapy interval on recurrence in breast-conserving treatment of small breast cancer. Int J Radiat Oncol Biol Phys. 1995;32(suppl 1, abstr):260.
17. Whelan TJ, Clark RM, Levine MN, et al. The effect of delay in initiating radiotherapy post lumpectomy on local breast recurrence. Int J Radiat Oncol Biol Phys. 1996;36(suppl 1, abstr):280.
18. Clarke DH, Le MG, Sarrazin D, et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1985;11:137-145.
19. Vujovic O, Perera F, Dar AR, et al. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat Oncol Biol Phys. 1998;40:869-874.
20. Froud PJ, Mates D, Jackson JS, et al. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys. 2000;46:363-372.
21. Ampil FL, Burton GV, Li BD, et al. Radiotherapy with and without chemotherapy after breast conservation surgery for early stage breast cancer: a review of timing. Eur J Gynaecol Oncol. 1999;20:254-257.
22. Bahena J, Labastida AS, Ayala HJ, et al. Impact of the interval between surgery and radiotherapy in the initial phases of breast cancer in patients who did not receive systemic adjuvant therapy. Ginecol Obstet Mex. 1998;66:87-91.
23. Slotman BJ, Meyer OW, Njo KH, et al. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol. 1994;30:206-212.
24. Hartsell WF, Recine DC, Griem KL, et al. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer. 1995;76:2497-2503.
25. Buchholz TA, Austin-Seymour MM, Moe RE, et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1993;26:23-35.
26. Recht A, Come SE, Gelman RS, et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol. 1991;9:1662-1667.
27. Leonard CE, Wood ME, Zhen B, et al. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control? J Clin Oncol. 1995;13:2906-2915.
28. Meek AG, Park TL, Weiss TA, et al. Effect of delayed radiation therapy on local control in breast conservation therapy. Radiology. 1996;200:615-619.
29. McCormick B, Norton L, Yao TJ, et al. The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery. Cancer J Sci Am. 1996;2:39.
30. Buzdar AU, Kau SW, Smith TL, et al. The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer. 1993;71:3680-3684.
31. Recht A, Come SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med. 1996;334:1356-1361.
32. Dendale R, Mouret-Fourme E, Campana F, et al. Sequence of radiotherapy and chemotherapy after breast-conserving surgery in small invasive breast cancer (abstract). Int J Radiat Oncol Biol Phys. 2000;48:291-292.
33. Buchholz TA, Hunt KK, Amosson CM, et al. Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am. 1999;5:159-164.
34. O'Sullivan B, Mackillop W, Grice B, et al. The influence of delay in the initiation of definitive radiotherapy in carcinoma of the tonsillar region (abstract). Int J Radiat Oncol Biol Phys. 1998;42(suppl 1):S97.
35. Lee AW, Chan DK, Fowler JF, et al. T1 nasopharyngeal carcinoma: the effect of waiting time on tumor control. Int J Radiat Oncol Biol Phys. 1994;30:1111-1117.
36. Brouha XD, Op DC, Terhaard CH, et al. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryngol. 2000;25:215-218.
37. Barton MB, Morgan G, Smee R, et al. Does waiting time affect the outcome of larynx cancer treated by radiotherapy? Radiother Oncol. 1997;44:137-141.
38. Dixit S, Vyas RK, Toparani RB, et al. Surgery versus surgery and postoperative radiotherapy in squamous cell carcinoma of the buccal mucosa: a comparative study. Ann Surg Oncol. 1998;5:502-510.
39. Kajanti M, Holsti LR, Holsti P. Radical surgery and postoperative split-course radiotherapy in squamous cell carcinoma of the mobile tongue: factors influencing local control and the time of recurrence. Radiother Oncol. 1991;22:174-179.
40. Vikram B, Strong EW, Shah J, et al. Elective postoperative radiation therapy in stages III and IV epidermoid carcinoma of the head and neck. Am J Surg. 1980;140:580-584.
41. Trotti A, Klotch D, Endicott J, et al. A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1993;26:13-21.
42. Ampil FL, Buechter KJ, Bairnsfather LE, et al. Timing and dosage of postoperative radiotherapy for squamous cell carcinoma of the upper aerodigestive tract. J Oral Maxillofac Surg. 1993;51:1194-1197.
43. Bastit L, Blot E, Debourdeau P, et al. Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys. 2001;49:139-146.
44. Schiff PB, Harrison LB, Strong EW, et al. Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer. J Surg Oncol. 1990;43:203-208.
45. Jensen AR, Mainz J, Overgaard J. Impact of delay on diagnosis and treatment of primary lung cancer. Acta Oncol. 2002;41:147-152.
46. Fried DB, Morris DE, Hensing TA, et al. Timing of thoracic radiation therapy in combined modality therapy for limited-stage small cell lung cancer: a meta-analysis. Lung Cancer. 2003;41:S23.